TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive In Brief: NCAB Meeting Set For Oct. 3-5; Second Workshop On Tumor Cell Cloning Jan. 3-5 August 24, 1979